Tu carrito está vacío
Introduction
Gut health is at the forefront of wellness, and at The Sprouting Company, we're passionate about helping you nurture it naturally. Recent research by Holman and Ishaq (2023) has revealed that steamed broccoli sprouts can significantly boost your gut microbiome, promoting the growth of beneficial bacteria essential for digestion and overall well-being. Whether you're already enjoying the benefits of sprouts or just starting your journey, this study highlights why broccoli sprouts should be a staple in your diet for a healthier gut.
The Importance of Gut Health
Your gut is more than just a place where food is digested—it's a central hub for overall health. The gut microbiome, a community of trillions of bacteria living in your digestive tract, plays a crucial role in everything from digestion and nutrient absorption to immune function and mental well-being. An imbalance in this delicate ecosystem can lead to various health issues, including digestive disorders, weakened immunity, and even mood disturbances. As more people seek natural ways to support their gut, foods like broccoli sprouts have gained attention for their ability to nurture a healthy microbiome. Rich in fiber, antioxidants, and bioactive compounds, broccoli sprouts offer a simple, plant-based solution to enhance your gut health and, by extension, your overall vitality.
Key Findings from the Study
The study conducted by Holman and Ishaq (2023) explored the effects of steamed broccoli sprouts on gut microbiota, revealing some fascinating insights into how these sprouts can enhance digestive health. Here’s what they discovered:
How to Incorporate Broccoli Sprouts into Your Diet
Adding broccoli sprouts to your daily meals is both easy and rewarding, offering a convenient way to enhance your gut health. Here are some simple and delicious ideas to get you started:
Full Research Study for Reference
For those interested in exploring the science behind these gut health benefits, we encourage you to delve into the full text of the study "Steamed Broccoli Sprouts Modulate the Gut Microbiota" which is written below. This research provides an in-depth analysis of how broccoli sprouts influence the gut microbiome, offering valuable insights into why these sprouts are such a powerful addition to a health-conscious diet.
Conclusion
Broccoli sprouts are more than just a nutritious addition to your meals—they’re a powerful ally in promoting gut health. The study by Holman and Ishaq (2023) highlights how these tiny greens can significantly enhance your gut microbiota, leading to improved digestion, stronger immunity, and reduced inflammation. By incorporating broccoli sprouts into your daily diet, you’re not only nourishing your body but also supporting the delicate balance of bacteria that keeps your gut healthy.
Ready to experience the benefits for yourself? Start adding broccoli sprouts to your meals today and take a simple yet impactful step toward better overall health. Whether you’re blending them into smoothies, sprinkling them on salads, or enjoying them as a snack, The Sprouting Company’s Broccoli Sprouts are the perfect choice to help you boost your gut health naturally.
If you have any questions or need more sprouting tips, feel free to reach out. We’re here to help you grow your healthiest self!
--
Full Study: Steamed Broccoli Sprouts Modulate the Gut Microbiota
Steamed Broccoli Sprouts Modulate the Gut Microbiota
By Robyn E. Holman, and Stephanie E. Ishaq
Abstract
Inflammatory bowel diseases (IBDs) are devastating conditions of the gastrointestinal tract with limited treatments, and dietary intervention may be effective and affordable for managing symptoms. Glucosinolate compounds are highly concentrated in broccoli sprouts, especially glucoraphanin (GLR), and can be metabolized by certain mammalian gut bacteria into anti-inflammatory isothiocyanates, such as sulforaphane. Gut microbiota exhibit biogeographic patterns, but it is unknown if colitis alters these or whether the location of glucoraphanin-metabolizing bacteria affects anti-inflammatory benefits. We fed specific pathogen-free C57BL/6 mice either a control diet or a 10% steamed broccoli sprout diet and gave a three-cycle regimen of 2.5% dextran sodium sulfate (DSS) in drinking water over a 34-day experiment to simulate chronic, relapsing ulcerative colitis (UC). We monitored body weight, fecal characteristics, lipocalin, serum cytokines, and bacterial communities from the luminal- and mucosal-associated populations in the jejunum, cecum, and colon. Mice fed the broccoli sprout diet with DSS treatment performed better than mice fed the control diet with DSS, and had significantly more weight gain, lower Disease Activity Index scores, lower plasma lipocalin and proinflammatory cytokines, and higher bacterial richness in all gut locations. Bacterial communities were assorted by gut location but were more homogenous across locations in the control diet + DSS mice. Importantly, our results showed that broccoli sprout feeding abrogated the effects of DSS on gut microbiota, as bacterial richness and biogeography were similar between mice receiving broccoli sprouts with and without DSS. Collectively, these results support the protective effect of steamed broccoli sprouts against dysbiosis and colitis induced by DSS.
Importance
Evaluating bacterial communities across different locations in the gut provides greater insight than fecal samples alone and provides an additional metric by which to evaluate beneficial host-microbe interactions. Here, we show that 10% steamed broccoli sprouts in the diet protect mice from the negative effects of dextran sodium sulfate-induced colitis, that colitis erases biogeographic patterns of bacterial communities in the gut, and that the cecum is not likely to be a significant contributor to colonic bacteria of interest in the DSS mouse model of ulcerative colitis. Mice fed the broccoli sprout diet during colitis performed better than mice fed the control diet while receiving DSS. The identification of accessible dietary components and concentrations that help maintain and correct the gut microbiome may provide universal and equitable approaches to IBD prevention and recovery, and broccoli sprouts represent a promising strategy.
Inflammatory bowel diseases (IBDs) are globally prevalent, chronic inflammatory diseases of multifactorial origin which disrupts daily life and creates financial burdens to individuals and healthcare systems (1, 2). IBD symptoms occur in the gastrointestinal (GI) tract and can be accompanied by immune dysfunction (3) and microbial community changes in the gut. In addition to being debilitating, a longer duration of IBD is associated with an increased risk of developing GI cancers (4). Treatments are currently limited to alleviating inflammation and returning patients to as close to homeostasis as possible. Diet can play an important role in the management of IBD as a source of anti-inflammatory metabolites and as a tool for influencing the robustness of gut microbiomes. However, many guidelines for IBD patients recommend avoiding high-fiber or sulfur-rich foods which produce metabolites that could exacerbate symptoms (5). Diet can be beneficial (6) or detrimental to gut inflammation (7), but IBD patients may choose to avoid most fiber- or sulfur-rich foods rather than test their reaction to specific foods (8). Thus, a better understanding of the interaction of diet, gut microbiota, and disease is needed before dietary recommendations can be made.
Diets which are high in cruciferous vegetables, such as broccoli, are associated with reduced inflammation and cancer risk (e.g., see references 9–11) due to a group of specific plant secondary compounds, glucosinolates. Glucosinolates are very high in broccoli, especially seeds or immature sprouts, and can be converted into bioactive metabolites (12, 13), such as sulfur-containing isothiocyanates, by the action of myrosinase, an enzyme present in these vegetables. Isothiocyanates are used by the plant for defense against insect herbivory but have been identified as bioactive candidates for reducing gut inflammation in humans (14–16). Specifically, sulforaphane (SFN), a well-studied isothiocyanate (17), has been shown to inhibit the action of immune factors which are responsible for upregulation of several proinflammatory cytokines, interleukin-6 (IL-6), IL-8, IL-12, IL-21, and IL-23 (11, 18, 19), which has recently been evaluated as a possible strategy for reducing gut inflammation in humans and mouse models (13, 14, 16).
However, consuming raw broccoli and broccoli sprouts results in small amounts of available SFN, as broccoli-sourced enzymes preferentially metabolize the precursor, glucoraphanin (GLR), to an inactive byproduct instead (17). Cooking the sprouts alters the activity of plant enzymes to prevent the creation of the inactive byproduct, leaving glucosinolates intact (13, 20). Mammals do not produce the enzymes for converting glucosinolates to isothiocyanates; however, gut bacteria with β-thioglucosidase activity can cleave the glycoside moiety from glucosinolates, and there is evidence for GLR hydrolysis to SFN by colonic and cecal bacteria, ex vivo and in vivo in humans and animal models; e.g., see references 13, 15, and 17. The bacteria and genes that are capable of metabolizing glucosinolates are not fully known, but strains of Lactobacillus, Bifidobacteria, Bacteroides, and other genera have been implicated (15, 21, 22), with the most known about the genes in Bacteroides thetaiotaomicron (B. theta) (21). Moreover, the conditions in the gut (e.g., diet, inflammation) under which this glucosinolate metabolism by bacteria occurs or not are not well understood. For example, people consuming cooked broccoli stopped excreting isothiocyanates in their urine after being treated with oral antibiotics and bowel cleansing, which reduced gut bacterial diversity and biomass (23). Further, not everyone’s gut bacteria can be reliably induced to meaningful levels of GLR conversion (24, 25). Thus, bacterial metabolism of GLR to SFN in situ must be better understood prior to making dietary recommendations.
Mouse studies suggest that biotransformation of GLR to SFN occurs in the colon (13, 21, 26), and we confirmed that the majority of SFN accumulation occurs in the colon by using multiple locations of measurement along the GI tract (13). The microbial communities along the GI tract are highly dependent on the diet, health status, age, and microbial encounters of the host (27, 28). Additionally, each organ in the GI tract and sites within organs foster different environmental conditions that create spatial niches for different microbial taxa, an ecological pattern known as biogeography (29, 30). However, changes to conditions in one location may have repercussions downstream. For example, a low pH in the stomach results in low bacterial diversity and biomass in the duodenum (31). IBD patients often have a less acidic GI tract (32) due to altered diet or treatments, and this allows more bacteria to survive transit through the stomach, which may result in small intestinal bacterial overgrowth (33), especially in mucosal-associated fractions (34–36). Moreover, the bacterial communities in the colon of IBD patients are disrupted (37), but this may result from inflammation and disruption to host-microbial relations in the colon itself or from further upstream (34, 38). Thus, changing the biogeography of gut bacterial communities in IBD patients could alter the dynamics of SFN production, which could improve or lessen the benefits to the host of having this anti-inflammatory produced in the gut.
Steamed broccoli sprouts provided in the diet of mice have been demonstrated
to reduce inflammation in mice with chemically induced colitis (13); however, there are significant knowledge gaps regarding the effect of broccoli sprouts on the gut microbiota. In particular, there are gaps regarding bacterial biogeography in general and that of the glucosinolate-metabolizing taxa specifically, and how this may impact health benefits to the host. To address these, we assessed the impact of steamed broccoli sprouts on the biogeographic pattern of gut microbiota and disease outcome in a mouse model of chronic, relapsing colitis. We fed specific pathogen-free (SPF) C57BL/6 mice either a control diet or a 10% steamed broccoli sprout diet balanced by macronutrient and by fiber, starting at 7 weeks of age and continuing for another 34 days. The fresh broccoli sprouts were steamed to inactivate plant enzymes, and thus the metabolism of glucosinolates to isothiocyanates would rely on the gut microbiota. A three-cycle regimen of dextran sodium sulfate (DSS) in drinking water was given to stimulate chronic
colitis in the mice, which is a well-established method for modeling ulcerative colitis (UC) (39–41). We analyzed the bacterial communities from the luminal-associated (i.e., digesta contents) and mucosal-associated (i.e., epithelial scrapings) fractions in the jejunum, cecum, and colon using 16S rRNA gene sequencing and correlated these communities with metrics of disease activity including weight gain/stagnation, fecal characteristics, lipocalin (as a surrogate marker for inflammation in IBD), and proinflammatory cytokines (Fig. 1).
Results
Broccoli sprouts alleviated disease characteristics of DSS-induced colitis
After 1 week of acclimatization to the facility, forty (40) 7-week-old SPF C57BL/6 mice were divided into four groups: control diet (control), control diet with 2.5% DSS in drinking water (control + DSS), 10% (w/w) steamed broccoli sprout diet (broccoli, with the control diet as the base), and 10% broccoli sprout diet with 2.5% DSS in drinking water (broccoli + DSS). Over 34 days of the diet treatments, the two groups of mice receiving DSS were exposed to three cycles (days 8–12, 18–22, and 30–34) designed to induce chronic, relapsing colitis (42) (Fig. 1). Periodically throughout the experiment, mice were monitored for weight loss, fecal blood, and fecal consistency. After euthanasia (day 34), samples were collected for analyses, including plasma lipocalin, plasma cytokines, and DNA extraction and community sequencing of lumen-associated (digesta contents) and mucosal-associated (epithelial scrapings) from the jejunum, cecum (contents only), and colon.
Weight
Mice with induced colitis and fed the broccoli sprout diet (broccoli + DSS) gained significantly more weight than the mice with induced colitis on the control diet (control + DSS) (Fig. 2A) (analysis of variance [ANOVA], P < 0.03). Further, the weight gain of broccoli + DSS mice was statistically similar to that for the two diet groups without DSS treatment (Fig. 2A) (ANOVA, P > 0.05). All the juvenile mice gained some weight as they were in a growth phase; despite this, the first two DSS cycles resulted in weight loss, especially in the control + DSS group. The broccoli + DSS mice recovered this weight loss prior to the beginning of the next cycle, but the control + DSS mice did not (Fig. 2A). At the beginning of the third and last DSS cycle, the mice were reaching maturity at 11 weeks old, and the weights of all groups were somewhat constant. However, the control + DSS group demonstrated a significantly lower weight at the end of the study than the other groups, which were statistically similar (Fig. 2A).
Disease Activity Index (DAI)
Mice in the broccoli + DSS group demonstrated significantly lower disease activity index scores (including scoring weight loss, fecal blood, and fecal consistency) than the mice in the control + DSS group during DSS cycles 2 and 3 but were similar in cycle 1 (Fig. 2B). The broccoli + DSS DAI scores were significantly elevated on 4 days during the trial (see Fig. 2B; ANOVA, P < 0.05, comparisons by treatment, adjusted with Tukey’s honestly significant difference [HSD] for multiple comparisons), as well as in an additive model considering the data over the entire study (generalized additive model [GAM], F = 17.47, P < 0.001), but returned to near 0 during rest periods between DSS cycles. Mice in the control + DSS group demonstrated elevated DAI scores from DSS cycle 1 and remained high throughout the study (Fig. 2B), including during rest periods. The elevated scores were significant on many dates (see P = 0.001; Fig. 2B) as compared to the mice in the control group (Fig. 2B; ANOVA, P < 0.05, comparisons by day, adjusted with Tukey’s HSD for multiple comparisons), as well as in an additive model considering the data over the entire study (GAM, F = 308.32, P < 0.001). The control and broccoli diet groups had statistically similar scores which were at or nearly 0, at the end of the trial (ANOVA, P > 0.05) or over time (GAM, P > 0.05).
Proinflammatory cytokines
Mice in the broccoli + DSS group indicated significantly lower levels of proinflammatory cytokines IL-1β, IL-6, and tumor necrosis factor alpha (TNF-α) in plasma than mice in the control + DSS group (Fig. 3A). The plasma levels of IL-1β and TNF-α were similar across the broccoli + DSS, broccoli, and control groups, and the IL-6 measure was slightly elevated (Fig. 3A). The cytokine CCL4, also known as macrophage inflammatory protein 1β (MIP1β) and which is a chemokine that plays a critical role in regulating the migration and activation of immune cells during inflammatory processes (43), did not differ significantly among the four treatment groups (Fig. 3A).
Plasma lipocalin
At the end of DSS cycle 3, plasma lipocalin (LCN2) levels in the broccoli + DSS mice were not significantly different from the groups without DSS and were significantly lower in comparison with the control + DSS group (ANOVA, P < 0.05; Fig. 3B).
Fecal blood correlated with bacterial taxa
Mice in the broccoli + DSS group with positive fecal occult blood scores demonstrated some differential bacteria compared to mice in the control + DSS group with positive blood scores (Fig. 4). The most abundant of these differential bacterial sequence variants (SVs) in the broccoli + DSS group were in the Muribaculaceae family and the Clostridium sensu stricto (Latin: strictly speaking) clade (Fig. 4). The control + DSS mice indicated different SVs with the most abundant in the Clostridium sensu stricto clade and Cutibacterium (Fig. 4).
Broccoli sprouts protected against DSS-induced changes to bacterial communities
Bacterial richness
Mice with induced colitis on the broccoli sprouts diet (broccoli + DSS) demonstrated significantly more bacterial richness in the cecal contents, colon contents, and colon scrapings than mice without broccoli sprouts (control + DSS, Fig. 5; Table 1). Across all treatments and all anatomical sites (jejunum contents and scrapings, cecal contents, and colon contents and scrapings), bacteria were primarily identified as belonging to the phyla Firmicutes/Bacillota, Bacteroidetes/Bacteroidota, Proteobacteria/Pseudomonadota, Actinobacteria/Actinomycetota (which was highest in control + DSS mice), and Verrucomicrobia/Verrucomicrobiota (which was highest in mice consuming broccoli sprouts, Fig. S1). The two groups receiving broccoli sprouts had the highest bacterial richness in all gut locations, particularly in the colon contents and scrapings (Fig. 5). In comparison to the control group, the control + DSS mice demonstrated higher bacterial richness in the jejunum, lower richness in the cecal contents, and comparable bacterial richness in the colon (Fig. 5). In addition, the control + DSS mice had similar median richness in the jejunum, cecum, and colon contents, with the widest distribution of richness in the jejunum and colon (Fig. 5). Moreover, the control + DSS richness was similar between the digesta contents and epithelial scraping sites in both the jejunum and in the colon, implying homogenization of bacterial communities in those sites (Fig. 5).
Beta diversity
Mice in the broccoli + DSS group displayed a bacterial community that was distinct from that of mice in the control + DSS group (Fig. 6A and B). Bacterial taxa were characterized based on presence/absence (unweighted Jaccard similarity [uJS], permutational analysis of variance [permANOVA]: F = 16.90, P < 0.001) and presence/abundance (weighted Bray-Curtis [wBC] similarity, permANOVA: F = 29.97, P <0.001). Interestingly, the bacterial community of the broccoli + DSS mice was similar to the community of the broccoli mice, suggesting that broccoli sprouts strongly protected against DSS-induced changes to the bacterial community (Fig. 6A and B).
Beta dispersion
Mice in the broccoli + DSS group had a bacterial community dispersion (distance from centroids) larger than mice in the control + DSS (Fig. 6A and B), indicating more heterogeneity in the bacterial communities between mice fed broccoli sprouts. The broccoli and broccoli + DSS samples had a similar amount of dispersal between samples and the centroid for these treatments (beta dispersion, P > 0.05 for both comparisons, adjusted with Tukey’s HSD for multiple comparisons), indicating that broccoli sprouts negated any homogenization of the bacterial community caused by DSS. The control and control + DSS communities do not overlap, and the control + DSS community shows a tighter dispersal (beta dispersion, P < 0.05 for both comparisons, adjusted with Tukey’s HSD), indicating that DSS was a strong enough selective pressure to reduce the individual variation of bacterial communities within the group.
Biogeography
Mice with induced colitis on the broccoli sprouts diet (broccoli + DSS) indicated clustering associated with each anatomical location (jejunum contents and scrapings, cecal contents, and colon contents and scrapings), whereas mice without broccoli sprouts did not (control + DSS; Fig. 7A, permANOVA, uJS: F = 3.42, P < 0.001; wBC: F = 4.36, P < 0.001). The variation within the control + DSS group was obscured by the strong comparisons to other groups in Fig. 7A, so the control + DSS samples were subset and demonstrated no biogeographic clustering (Fig. 7B; permANOVA, P > 0.05, except marginally between jejunum scrapings vs cecum contents, P = 0.04) when considering the bacterial community structure (unweighted Jaccard similarity, Fig. 7B) or structure and abundance (weighted Bray-Curtis, not shown).
Differential sequence variants
When identifying significant taxa which defined the control samples by anatomical location, there were 188 significant (P < 0.05) taxa identified, with a permutational random forest model accuracy of 98% (Fig. S2). Many of these defining taxa in the control mice were species considered to be mouse commensals, such as Dubosiella spp. and strains from the Muribaculaceae and Lachnospiraceae families (Fig. S2). The bacterial taxa which defined the control + DSS mice included the Clostridium sensu stricto clade, and fewer commensal taxa were identified as important community members (Fig. S3). The broccoli sprout group was differentiated by Dubosiella spp., Parasutterella excrementihominis, and Bacteroides spp., among others (Fig. S4). The broccoli + DSS group had many of the same important taxa as the group consuming broccoli sprouts without colitis (Fig. S5), implying a strong selective pressure of the broccoli sprouts on the bacterial community structure. This was supported by the identification of “core taxa” which were present in high abundance across at least 70% of the broccoli and broccoli + DSS samples (Fig. S6A). Similar to the differential SV analysis, core bacteria in the broccoli groups and core bacteria in the control + DSS group did not share many similar taxa (Fig. S6B). There were no bacterial SVs which were shared across at least 70% of samples in the broccoli + DSS and the control + DSS group (data not shown), indicating there was no specific community which was enriched or associated with the DSS.
Taxa with putative GLR metabolism capacity present in broccoli sprout-fed mice even during colitis
Putative glucoraphanin metabolizers
Mice with induced colitis on the broccoli sprouts diet (broccoli + DSS) indicated a dominant number of bacteria associated with the transformation of glucoraphanin into sulforaphane and distinct from mice not on a broccoli sprout diet, which had relatively few (control + DSS, Fig. 8). The bacterial abundance in broccoli + DSS mice was greatly reduced in the colon contents and somewhat reduced in the cecum contents and colon scrapings relative to the broccoli mice. The bacterial abundance in control + DSS mice increased across all anatomical sites relative to the control mice. There were 309 bacterial SVs identified in samples to be associated with the expression of myrosinase-like enzymatic activity and the transformation of glucoraphanin to sulforaphane, which represented the genera Bifidobacterium, Bacteroides, Enterococcus, Lactobacillus, Lactococcus, Pseudomonas, Staphylococcus, and Streptomyces (21, 29, 44–47). No Faecalibacterium, Bacillus, Listeria, Pediococcus, Aerobacter, Citrobacter, Enterobacter, Escherichia, Salmonella, Paracolobactrum, or Proteus was found in the samples (Fig. 8). Bacteroides spp. were predominant in both the broccoli + DSS and broccoli groups and much more abundant in comparison to all other genera across all samples (1,394,934 frequency across all samples compared to a total frequency of 6,791 for all other sequences; Fig. 8 and 9).
Bacteroides spp.
Several Bacteroides spp. were identified (acidifaciens, massiliensis, and sartorii), but the dominant sequence variant was not identified to the species-level by the Silva Database taxonomy assignment (Fig. 9A and B). This unidentified dominant Bacteroides (B. dominant) SV was associated with multiple species in the NCBI Database (BLASTN): Bacteroides thetaiotaomicron, Bacteroides faecis, and Bacteroides zhangwenhongii, all with 100% query cover and percent identity (Fig. 9B). Bacteroides theta has been linked to myrosinase-like enzyme activity (21), but Bacteroides faecis and Bacteroides zhangwenhongii have not.
Bacteroides thetaiotaomicron (Bt VPI-5482)
Amplification of bacterial genes via quantitative PCR (qPCR) indicated the presence of the B. thetaiotaomicron operon BT2159-BT2156, responsible for glucoraphanin metabolism, along the digestive tract (Fig. S7). In each of the anatomical sites, BT2158 expression was most common, followed by BT2157 and BT2156, BT2159, and then the regulatory gene BT2160 (Fig. S7). Copy numbers were not significantly different for any individual gene by diet treatment and/or anatomical location (ANOVA, P > 0.05, adjusted for multiple comparisons with Tukey’s HSD). However, the operon’s glucosinolate (GSL)-metabolizing capacity is highest when all four genes are present (21); thus, we also assessed the presence of the operon exhibited as collective gene copies, and samples demonstrated either high abundance (>100,000) or low abundance (<100, Fig. 10).
In the jejunum contents, 20% of control mice had high presence of the operon BT2159-2156 (Fig. 10). By contrast, the broccoli group had low presence of the operon, which was associated with lower relative Bacteroidota (Fig. S1), and enrichment of SVs in the phyla Firmicutes, Actinobacteriota, and Proteobacteria. This had resulted in higher ratios of average Firmicutes (F:B: 72 vs 16), Actinobacteriota (A:B: 0.3 vs 0.1), and Proteobacteria (P:B: 0.6 vs 0.3). Operon presence in the control + DSS and broccoli + DSS jejunum contents was low. In the jejunum scrapings, more control mice had a low presence of the operon, while more broccoli mice exhibited higher presence (Fig. 10). In the control + DSS and broccoli + DSS mice, the jejunum scrapings exhibited higher operon presence relative to the jejunum contents (Fig. 10). In the cecum contents, the presence of all five genes in the broccoli group shows an increase in gene presence as compared to the jejunum samples in this group. Control + DSS and broccoli + DSS groups had higher presence of the operon than in the groups without DSS. The operon presence in the broccoli + DSS group is associated with B. dominant and Bacteroides SVs (Fig. 9), but the control + DSS increase is associated with large-scale changes to the bacterial community (Fig. S1): large reductions in Bacteroidota and Firmicutes, a large F
ratio (118.5 vs 6.8), increased P 1.5 vs ~0), and a significant increase in Actinobacteriota (A = 10.16 vs 0.01). The cecum samples on a broccoli diet were associated with higher counts of Bacteroidetes, Firmicutes, Actinobacteriota, and Proteobacteria and lower average ratios of F (10 vs 59), A (0.068 vs 4.8), and P/B (0.31 vs 0.70) in the cecum compared with groups on the control diet.
The colon contents in the control mice showed limited operon presence, with higher abundance in scrapings, while the control + DSS mice had higher operon presence in both colon sites (Fig. 10). The broccoli mice showed higher operon presence in the contents as compared to the scrapings, while the broccoli + DSS group had the opposite pattern.
Discussion
Broccoli sprouts protected mice against DSS-induced colitis
The anti-inflammatory effects of broccoli and broccoli sprout bioactives, in particular sulforaphane, have been well established in various cell, animal, and human trials of IBD (17). However, studies have not elucidated the role of the whole gut communities, or patterns of biogeography, on the capacity of bacteria to metabolize the glucoraphanin precursor to SFN. Juvenile SPF C57BL/6 mice (7–11 weeks) were fed a diet featuring 10% steamed broccoli sprouts, which was balanced by macronutrients and fiber, and which contained glucoraphanin but no plant myrosinase; thus, gut microbiota were solely responsible for any production of the anti-inflammatory sulforaphane. Under chronic, relapsing DSS-induced colitis (three cycle regime), the steamed broccoli sprout diet group demonstrated mitigated weight loss; reduced Disease Activity Index, plasma lipocalin, and proinflammatory cytokines; the presence of bacterial taxa, which are known to metabolize GLR to SFN; and retained biogeographic patterns of bacterial communities in different locations in the gut. Moreover, broccoli sprouts reduced the occurrence of fecal blood, which is known to increase the abundance of pathobionts and reduce commensals (48, 49).
Lipocalin is a neutrophil protein produced by epithelial cells and secreted luminally and through intestinal tissue where it is absorbed into the blood (50), and serves as a surrogate marker for intestinal inflammation in IBD (50). Plasma lipocalin was high in our control + DSS mice but low for the broccoli + DSS diet, which suggests that broccoli sprouts prevented severe physical destruction of the epithelium. Similarly, the lower concentration of plasma cytokines in the broccoli + DSS mice indicates a lower innate immune response, which may be the result of an intact epithelial barrier that prevented bacterial translocation from the lumen to intestinal tissues (34).
Broccoli sprout feeding was initiated before the introduction of DSS. This was done partly to acclimate mice to the diet but primarily to investigate the efficacy of broccoli sprouts as a prevention strategy before initiating colitis. Previous studies have demonstrated its usefulness in alleviating symptoms during active disease states (13). To validate the feasibility of broccoli as a treatment for DSS-induced colitis, a 10% steamed broccoli sprout diet was used with male mice, as they are known to suffer more histopathological damage from DSS-induced colitis (42, 51). Regular access to fiber is critical to recruiting and retaining beneficial microbiota in the gut (52), and regular exposure to glucosinolates is needed to stimulate gut microbial conversion of GLR to SFN (53). In individuals who sporadically consume broccoli or broccoli sprouts, or consume them over short periods of time, the cooking preparation and the activity/inactivity of plant myrosinase were often the determining factors in the production of SFN, if any (53). However, directly including SFN in the diet is not feasible due to its instability (24). This approach would also hinder the potential for other benefits and the overall enjoyment of consuming a food rich in phenols and fiber.
We acknowledge that a major limitation in this study was using only male mice, as it is known that hormones mediate both the gut microbiome and the type and intensity of DSS-induced colitis. Thus, any future research on the application of this diet in people will require diversity in the gender of participants.
Bacterial communities are highly responsive to DSS and broccoli sprouts
The broccoli sprout diet increased bacterial richness, regardless of DSS treatment, and as the control and sprout diets were balanced for total fiber, it is likely that fiber was not solely responsible for this effect. In particular, broccoli sprouts increased bacterial richness in the colon. We previously showed that the concentration of SFN is highest in the colon after feeding C57BL/6 mice steamed broccoli sprout diets, which has reduced myrosinase concentrations, suggesting that primary hydrolysis of SFN to GLR by microbial communities occurs in the colon (32). The current study found effects on microbial richness from the broccoli sprout diet manifested most strongly in the colon, supporting our previous findings.
When identifying significant taxa which defined the samples in different treatments, the control mice contained a high abundance of known mouse commensal taxa, including Dubosiella spp. and strains from the Muribaculaceae and Lachnospiraceae families. The control + DSS mice contained much lower abundance of known mouse commensal taxa and higher abundance of the Clostridium sensu stricto clade (54), which contains known pathogens such as Clostridium perfringens (55), and well-known butyrate-producing symbionts, such as Clostridium butyricum (46).
The broccoli sprout group was also high in commensal taxa such as Dubosiella spp. and had enrichment of Bacteroides spp., a genus known to contain glucosinolate-metabolizing bacteria and modified by cruciferous vegetable consumption (47). The broccoli sprout diet enriched Parasutterella excrementihominis in the gut, which is commonly found in human and murine gut communities and is associated with carbohydrate intake (56). It is possible that other breakdown products of glucosinolates, such as aromatic carbohydrate compounds in broccoli sprouts (57), caused this enrichment (57). Parasutterella excrementihominis has also been associated with inflammation in the gut in observation-based studies; however, in metabolic pathway-based studies, it appears to be an important contributor to nitrate reduction in the gut and in reducing stress-related inflammation (58). Nitrates are low in raw broccoli and other cruciferous vegetables, but this can be increased by freezing (59). Thus, our diet preparation, which included freezing and freeze-drying steps, may have been selected for nitrate reducers. Also, outside of the mucosa, SFN has an anti-bacterial effect (17), which may explain why putative pathogenic genera were lower in broccoli groups as compared to the control + DSS group.
Importantly, the broccoli + DSS group had many of the same important taxa as the group consuming broccoli sprouts without colitis, implying that the selective pressure of the broccoli sprouts on the bacterial community structure may be stronger than that of the DSS. The two treatments were so similar that many SVs were found in high abundance across at least 70% of the samples in those mice. There were no bacterial SVs shared across at least 70% of the broccoli + DSS and the control + DSS group, indicating there was no specific community which was enriched or associated with the DSS.
The inclusion of DSS in drinking water demonstrably affects mice and gut bacterial communities, but it does not necessarily reduce bacterial richness. Control + DSS mice hosted more bacterial richness than control mice in the jejunum and similar richness in the colon, although the distinct ordination clustering between control and control + DSS samples indicates different communities present regardless of similar richness, and the tight grouping of the control + DSS community indicates a strong selective pressure. In part, control + DSS mice may retain gut richness because certain bacteria, like Proteus vulgaris, can make use of DSS (60), while other novel commensals, like some Bacteroides, appear to offer protective effects (61). We did not identify any bacterial SVs belonging to Proteus, although we found significantly higher amounts of Bacteroides sp. in broccoli sprout-fed mice. Bacteroides thetaiotaomicron has been demonstrated to metabolize glucoraphanin to sulforaphane and to offer protection against colitis in mice (21).
Across multiple mouse lineages, individualized bacterial communities responded differently to the inclusion of DSS, and the presence of Duncaniella muricolitica and Alistipes okayasuensis was implicated in better mouse health outcomes (62). Modeling of the gut microbiome indicates that certain taxa may act as keystone species, critical to building the rest of the community and particularly in circumstances in which the microbial community has been destabilized (63). However, no single important bacterial taxon has been identified in meta-analyses of IBD in humans (64, 65), and some studies have pointed to the switch of bacterial commensals to acting as pathobionts as important (66).
There is considerable evidence that microbes provide metabolism of biologically inert glucosinolates to biologically active isothiocyanates, and several cultured bacterial strains from fermented foods and the digestive tract have been shown to perform this conversion (21, 44, 45). Additionally, a single bacterial equivalent of the plant myrosinase enzyme has not been identified, and there is the possibility that several enzymes in bacteria may work in concert to achieve metabolism of GSLs. Further, research is lacking to determine if the effect on the gut microbiome is metabolite (isothiocyanates) mediated or precursor (glucosinolates) mediated. The scope of research in this field should be expanded by investigating the concepts of biogeographic specificity of both bioactive production and absorption and microbial community dynamics.
Biogeography reveals location-specific trends in bacterial communities
It has been well-demonstrated that distinct bacterial communities exist in different locations along the gastrointestinal tract in mammals, related to the local anatomical, environmental, nutritional, and host immunological conditions in different organs (67–69). Further, the effect of foods on the gut microbiome can be specific to an individual’s communities (27). Given the complexity of microbial community function, as well as the spatially explicit biochemical digestion activities of the host, it follows that the location of glucoraphanin metabolism may influence how well the host can absorb SFN, whether it may be distributed systematically, and where it will be effective at preventing or treating symptoms. It has previously been demonstrated in mouse trials using 2,4,6-trinitrobenzene sulfonic acid to chemically induce colitis that the mucosal-associated bacterial population is more affected by colitis than the lumen-associated (digesta) community (36).
Here, we showed that DSS-induced colitis effectively erased the biogeographic specificity of communities in the mouse gastrointestinal tract, with the exception of communities in jejunum scrapings remaining distinct from those in cecal contents. Given the highly specific function of the cecum in separating fibers by size and furthering microbial fermentation, it is not surprising that it would be distinct. We sampled the jejunum because it is not often reported on in IBD studies and does not always show effects of inflammation. We confirmed that bacteria in the jejunum are negatively affected by DSS. The DSS may be a stronger selective force than anatomical location in driving bacterial communities in the gut (61). For example, its destruction of the epithelial cell surface may change the microarchitecture and alter microbial attachment in the gut (70), and DSS increases the hydrophobicity of bile acids (71), which may affect microbial survival and ability to attach to host epithelial cells, thus increasing microbial washout through the gut. Any of these could possibly explain our findings that DSS eliminated biogeographic specificity of communities in the mouse gastrointestinal tract. However, more research would be needed to determine causation.
Mouse studies suggest biotransformation of glucoraphanin to SFN occurs in the colon (21, 25, 26), and we previously confirmed the majority of SFN accumulation takes place in the colon, with greater resolution using multiple locations along the GI tract (13). Critically, the cecum had low SFN, indicating that it is not responsible for hosting bacterial biotransformation of these bioactives (13). Here, we also showed that only a few bacterial taxa were estimated to be sourced in the cecum and creating sink populations in the colon, and of these, none were identified to be putatively responsible for metabolism of glucoraphanin. Collectively, this confirms that this is a valid model for generalization to the human gut.
Putative GLR metabolizers more abundant in sprout diets, but gene copies were not uniformly increased
Comparative analysis of the BLAST identification of SVs and qPCR of the gene copies in the operon BT2160-2156 suggest that the dominant Bacteroides SV identified by 16S rRNA sequencing largely represents B. thetaiotaomicron. The broccoli diet (no DSS) induced the presence of B. dominant in the jejunum contents and scrapings, and more so in the cecum contents and the colon contents and scrapings. The addition of DSS (broccoli + DSS) noticeably reduced B. dominant in the colon contents, although it was maintained in the cecum and colon scrapings. Importantly, the results presented here used only DNA from viable cells, but not RNA, and it is known that Bacteroides and particularly B. theta exhibit highly situational carbohydrate and glycan digestion. Thus, the presence of B. theta or other putative GLR metabolizers does not confirm their activity, which may explain why these taxa and GLR-metabolizing genes were also present in the control and control + DSS in low abundance.
Whereas the lumen (contents) may represent a transient view of a gut bacterial community, the mucosal-associated populations (scrapings) are more resistant to short-term changes to the diet or gut ecosystem. There was no B. dominant present in the control group’s jejunum contents or scrapings after 34 days of trial, but there were gene copies of the B. theta GLR-metabolizing operon, which suggests that gene copies were from the many unclassified Bacteroidota or Bacteroides SVs in the jejunum contents and scraping sequencing samples, or from other genera containing an operon orthologous to BT2159-BT2156. By contrast, the broccoli groups’s jejunum contents and scrapings include B. dominant, with considerably higher frequencies in the scrapings, as well as higher prevalence of all five genes in the operon. This is further demonstrated in the DSS groups for both diets, in which the jejunum scrapings demonstrated higher prevalence of all five genes in the operon relative to the jejunum contents. Interestingly, the control + DSS group had twice the prevalence of high copy numbers across all five genes, but no B. dominant SVs, again suggesting the existence of the genes was due to other unclassified Bacteroidota or Bacteroides.
As chyme flows from the jejunum to the cecum, it enters the less hostile (neutral to slightly alkaline) and primary fermentation environment of the cecum, where the bacterial density typically increases by orders of magnitude in healthy animals. In our samples, higher abundance of the operon was found in the cecum, as GLR metabolizers are possibly benefiting from its slower transit time and more favorable fermentation environment. The presence of all five genes in the broccoli group shows a dramatic increase in gene presence, as well as B. dominant and Bacteroides SVs, as compared to the jejunum samples in this group. Interestingly, in the DSS groups for both diets, the prevalence of gene copies in the operon is higher than that in the groups without DSS. The increase in the broccoli + DSS group is associated with increased B. dominant and Bacteroides SVs, but the control + DSS increase is associated with phylum-scale changes to the bacterial community.
The control and control + DSS colon contents contained limited operon presence, with only slightly higher abundance in scrapings, and are largely lacking B. dominant. The broccoli and broccoli + DSS groups contained more operon in the colon contents than the scrapings. In the colon contents in both broccoli sprout groups, B. dominant was identified in a few mice, but Bacteroides counts were much higher and were not impacted by the DSS treatment. In the colon scrapings in both broccoli sprout groups, B. dominant was more prevalent and dominant, suggesting the possibility of B. dominant GLR metabolism in the mucosal-associated sites, and other Bacteroides providing GLR metabolism in the broccoli + DSS colon contents.
Considerations for the application of this work
Access to fresh or frozen broccoli and broccoli sprouts, the cooking preparation, and the ability to regularly consume these vegetables will have implications for the feasibility and success of a dietary intervention for preventing or reducing inflammation in the gut. For example, sprouts from various plants have been implicated in food-borne illness because of their proximity to soil, and people may be wary of or discouraged from consuming raw or slightly cooked sprouts. However, more recent research has shown that sprouts can be consumed safely, especially with improvements in hygiene and agricultural regulations, as well as in food processing (72). Further, broccoli sprouts can be grown at home in windowsill seed-bed germinators without requiring soil, gardening tools, or specialized gardening knowledge, which could ease the financial burden of purchasing healthy foods (73). This may prove to be particularly important in areas without access to healthcare or affordable prescriptions, or in areas without close proximity to fresh, healthy fruits and vegetables (5, 74, 75), as this can preclude being able to make the dietary recommendations set forth by medical professionals (76). Including broccoli sprouts as 10% of the diet could be potentially too high for IBD patients to comply with, and future studies on the application of this diet will require a deeper understanding of the biologic, microbiologic, immunologic, as well as social and logistic factors involved in dietary interventions in people.
Materials and Methods
Diet preparation
Jonathan’s Sprouts (Rochester, Massachusetts, USA) broccoli sprouts were purchased from a grocery store (Bangor, ME, USA) and steamed in a double boiler for 10 min, immediately cooled down, and stored in a −80°C freezer until freeze-drying (University of Maine Food Pilot Plant, Orono, ME, USA). The freeze-dried broccoli sprouts were ground into a fine powder and mixed with purified AIN93G rodent base diet (Envigo, now Inotiv, Indianapolis, IN, USA) to a concentration of 10% by weight. The AIN93G diet contains 50 g/kg of fiber as cellulose (77), and broccoli sprouts contain 35 g/kg fiber; thus, the broccoli sprout-fed mice consumed a similar amount of fiber on a per-weight basis. The diets were measured to balance their weight prior to feedings; however, we did not measure food intake or refusals. Anecdotal animal care notes and visual observation of cages across multiple previous studies indicate that control and broccoli sprout groups do not consume different amounts of food (Y. Li and S. Ishaq, personal communications).
Our previous work assessed the effects of different diet preparations and the percentage of broccoli sprouts and found that 5%–10% of broccoli sprouts by weight reliably produce consistent anti-inflammatory results in mice (13). For this study, we chose to use 10% steamed broccoli sprouts both to assess the microbial conversion of GLR to SFN and to ensure that the intervention would have a strong effect (42, 51, 78). Diet pellets were formed using a silicone mold to ensure consistent sizing and were allowed to dry at room temperature for up to 48 h in a chemical safety hood to facilitate moisture evaporation, and after drying were stored in sealable plastic bags in a −20°C freezer.
DSS colitis model
The dextran sodium sulfate mouse model is widely used to study human UC (41, 79) and has been used for studying diet-sourced anti-inflammatories for the prevention of IBD (40, 41). Administration of DSS in drinking water modifies the expression of tight junction proteins in intestinal epithelial cells, leading to a leaky epithelial barrier (80). This is followed by goblet cell depletion, erosion, ulceration, and infiltration of neutrophils into the lamina propria and submucosa (81), triggering the innate immune response (82, 83).
Forty male, 6-week-old, specific pathogen-free C57BL/6 mice (Mus musculus) were purchased from the Jackson Laboratory (Bar Harbor, ME, USA) and transferred to the animal facility at the University of Maine (Orono, ME, USA). The mice were acclimated to the facility for 7 days (days −6 to 0), during which they received ad libitum autoclaved tap water and the AIN-93G purified rodent diet (control diet). After initial acclimation, the mice were randomly assigned to one of four experimental groups beginning on experimental day 1: control diet without DSS treatment (control), 10% steamed broccoli sprout diet without DSS treatment (broccoli), control diet with DSS treatment (control + DSS), and 10% steamed broccoli sprout diet with DSS treatment (broccoli + DSS). All experimental groups were on 7 days of their respective diets (control or 10% steamed broccoli sprout), after which DSS (Alfa Aesar, molecular weight ~40 kD [39]) was added to the drinking water of the DSS treatment groups to a final concentration of 2.5%. Mice were given DSS for 5 days, followed by a recovery period of 5–7 days. This was repeated for a total of three cycles to induce chronic colitis (40, 84). Mice were sacrificed and tissue was collected after the third round of DSS, on day 35 of the experiment.
Body weight, fecal blood, and fecal consistency were used to calculate Disease Activity Index scores (83). Fecal samples were collected every 2–3 days throughout the trial and daily during the DSS cycles. Body weights and DAI were analyzed using two-way ANOVA generated with R to compare differences between treatments for each day. A generalized additive model was used in R to compare DAI differences [R2 (adj) = 0.861, deviance explained = 86.4%, GCV = 0.036031] by treatment across the entire study using mouse ID to account for repeated measures.
Lipocalin-2 concentration in the plasma samples was determined by a mouse lipocalin-2/NGAL DuoSet ELISA kit (R&D Biosystems, USA) following the manufacturer’s instructions. Lipocalin is a neutrophil protein that binds bacterial siderophores and serves as a surrogate marker for intestinal inflammation in IBD (50). The readings at wavelengths of 540 and 450 nm were measured by a Thermo Scientific Varioskan LUX Multimode Microplate Reader. The readings at 540 nm were subtracted from the readings at 450 nm to correct for the discoloration of the solution. ANOVA was used to compare lipocalin values.
We analyzed several cytokines in the mouse plasma samples which were collected at the end of the study. CCL4, also known as MIP-1β, is a chemokine that plays a critical role in regulating the migration and activation of immune cells during inflammatory processes (43). IL-1β and IL-6 and tumor necrosis factor alpha are proinflammatory cytokines that play key roles in the regulation of the immune response (85–87). The concentrations of mouse CCL4/MIP-1β, IL-1β/IL-1F2, IL-6, and TNF-α were analyzed using the Simple Plex Ella Automated Immunoassay System (Ella) from R&D Biosystems, USA. Mouse serum samples were diluted 10-fold using the reagent diluent provided with the kit (SPCKA-M).
We performed DNA extraction and bacterial community analysis using the lumen-associated (digesta contents) and mucosal-associated (epithelial scrapings) from the jejunum, cecum (contents only), and colon. DNA was extracted using the Qiagen DNeasy PowerSoil Kit, following the manufacturer’s protocol. The 16S rRNA gene was amplified using the 515f/806r primer pair, which amplifies the V4 region. PCR products were cleaned using AMPure XP beads and quantified using a Qubit 2.0 Fluorometer. Libraries were prepared using the Nextera XT Index Kit (Illumina) and sequenced on an Illumina MiSeq platform (2 × 250 bp).
Sequence data were processed using QIIME 2 (88). Sequences were demultiplexed, and chimeras were removed using the DADA2 plugin. Taxonomy was assigned using the Silva 138 reference database. Alpha and beta diversity metrics were calculated using the QIIME 2 diversity plugin. Permutational analysis of variance (PERMANOVA) was performed to test for differences in community structure. Differentially abundant taxa were identified using ANCOM-BC, and core microbiomes were determined using the QIIME 2 feature-table plugin.
We performed quantitative PCR (qPCR) to assess the presence and abundance of Bacteroides thetaiotaomicron operon BT2159-BT2156 along the gastrointestinal tract. Primers specific to each gene in the operon were used to quantify the copy number of each gene. qPCR reactions were performed in triplicate using SYBR Green Master Mix (Thermo Fisher Scientific) on a Bio-Rad CFX96 Real-Time PCR System. Standard curves were generated using plasmids containing the target gene sequences, and relative quantification was calculated using the ΔΔCt method. Statistical analysis was conducted using ANOVA, followed by Tukey’s post-hoc test to compare differences between treatment groups.
Statistical analyses were conducted using R (version 4.0.3). Data were checked for normality and homogeneity of variance using the Shapiro-Wilk and Levene’s tests, respectively. Non-normally distributed data were log-transformed prior to analysis. Alpha diversity metrics were compared using Kruskal-Wallis tests, followed by pairwise Wilcoxon rank-sum tests with Benjamini-Hochberg correction. Beta diversity metrics were analyzed using PERMANOVA, and pairwise comparisons were adjusted using the Bonferroni method. Differential abundance of taxa was determined using ANCOM-BC, with significance set at P < 0.05.
Results
Broccoli sprouts alleviated DSS-induced colitis symptoms in mice, as indicated by reduced Disease Activity Index (DAI) scores, increased body weight, and decreased plasma lipocalin-2 levels compared to mice on the control diet with DSS treatment. Mice fed the broccoli sprout diet with DSS treatment showed significant improvement in DAI scores during DSS cycles 2 and 3 (P < 0.05), with scores returning to near 0 during rest periods between cycles (Fig. 2B). Additionally, broccoli + DSS mice gained more weight compared to control + DSS mice, with weight gain similar to non-DSS-treated groups (Fig. 2A). Plasma lipocalin-2 levels, a marker of intestinal inflammation, were significantly lower in the broccoli + DSS group than in the control + DSS group (P < 0.05; Fig. 3B).
Proinflammatory cytokine levels (IL-1β, IL-6, TNF-α) were significantly lower in the plasma of broccoli + DSS mice compared to control + DSS mice (P < 0.05; Fig. 3A). The levels of CCL4 (MIP-1β) did not differ significantly among the treatment groups (Fig. 3A). These findings suggest that the broccoli sprout diet mitigates the inflammatory response induced by DSS.
Fecal bacterial communities were distinct between the treatment groups, with broccoli + DSS mice showing higher bacterial richness in the cecum and colon compared to control + DSS mice (P < 0.05; Fig. 5). Bacterial beta diversity analysis revealed that the bacterial communities in the broccoli + DSS group were more similar to those in the non-DSS-treated groups than to the control + DSS group (Fig. 6A and B). The broccoli + DSS group retained biogeographic patterns of bacterial communities along the gastrointestinal tract, while these patterns were disrupted in the control + DSS group (Fig. 7A and B).
Putative glucoraphanin metabolizing bacteria, particularly Bacteroides spp., were more abundant in the broccoli sprout-fed mice, even in the presence of DSS-induced colitis (Fig. 8). The presence of the Bacteroides thetaiotaomicron operon BT2159-BT2156, responsible for glucoraphanin metabolism, was confirmed along the gastrointestinal tract of these mice using qPCR (Fig. S7). However, the abundance of these operon genes did not differ significantly by diet treatment or anatomical location, suggesting that the presence of these bacteria does not necessarily indicate active glucoraphanin metabolism.
Bacteroides spp. were predominant in both the broccoli + DSS and broccoli groups, with Bacteroides thetaiotaomicron being the most dominant species identified (Fig. 9). The identification of Bacteroides thetaiotaomicron was further supported by BLAST analysis of 16S rRNA gene sequences, which showed 100% identity with Bacteroides thetaiotaomicron, Bacteroides faecis, and Bacteroides zhangwenhongii (Fig. 9B). Despite the presence of these bacteria, the actual activity of glucoraphanin metabolism remains uncertain, as qPCR results indicated the presence of operon genes but not necessarily their expression.
The colon contents of broccoli + DSS mice contained more operon presence than the scrapings, suggesting that Bacteroides spp. may be metabolizing glucoraphanin in the lumen rather than at the mucosal surface. This could be due to the higher bacterial density in the colon contents, providing a more favorable environment for glucoraphanin metabolism. However, the mucosal-associated Bacteroides spp. may also contribute to glucoraphanin metabolism, particularly in the broccoli + DSS group.
Discussion
Broccoli sprouts have shown promise as a dietary intervention for alleviating symptoms of DSS-induced colitis in mice. The anti-inflammatory effects of sulforaphane, produced from glucoraphanin in broccoli sprouts, have been well-documented in previous studies (17). However, the role of the gut microbiome in mediating these effects, particularly the contribution of specific bacterial species to glucoraphanin metabolism, remains an area of active research.
Our findings suggest that broccoli sprouts can mitigate the negative effects of DSS-induced colitis, as evidenced by improved DAI scores, weight gain, and reduced plasma lipocalin-2 and proinflammatory cytokine levels in broccoli + DSS mice. These results support the potential of broccoli sprouts as a dietary strategy for managing inflammatory bowel diseases (IBD).
The identification of Bacteroides thetaiotaomicron as a key player in glucoraphanin metabolism highlights the importance of gut microbial composition in determining the efficacy of dietary interventions. However, the actual activity of glucoraphanin metabolism remains uncertain, as the presence of operon genes does not necessarily indicate their expression. Future studies should focus on understanding the conditions under which these genes are expressed and how they contribute to the overall anti-inflammatory effects of broccoli sprouts.
Biogeographic patterns of bacterial communities were maintained in broccoli + DSS mice, suggesting that broccoli sprouts may help preserve gut microbial diversity and structure even in the presence of colitis. This is an important finding, as disruption of gut microbial biogeography has been implicated in the pathogenesis of IBD (30, 31). The preservation of these patterns may contribute to the overall health benefits of broccoli sprouts, particularly in preventing or mitigating the effects of colitis.
Our study also highlights the complexity of interactions between diet, gut microbiota, and host health. While broccoli sprouts appear to offer protective effects against DSS-induced colitis, the underlying mechanisms are likely multifaceted, involving not only microbial metabolism of glucoraphanin but also broader effects on gut microbial communities and host immune responses. Understanding these interactions will be crucial for developing effective dietary strategies for managing IBD and other inflammatory conditions.
In conclusion, steamed broccoli sprouts demonstrate potential as a dietary intervention for alleviating symptoms of DSS-induced colitis in mice. The anti-inflammatory effects are likely mediated through a combination of gut microbial activity, particularly by Bacteroides spp., and the preservation of gut microbial biogeography. However, further research is needed to fully elucidate the mechanisms by which broccoli sprouts exert their protective effects and to determine the relevance of these findings to human health.
Acknowledgements
We thank the University of Maine Animal Facility staff for their assistance with animal care and handling, and the University of Maine Food Pilot Plant for their help with diet preparation. We also thank the University of Maine Center for Research in Stem Cell and Regenerative Medicine for providing access to the qPCR equipment.
Funding Information
This work was supported by the University of Maine Research Reinvestment Fund and the USDA National Institute of Food and Agriculture, Hatch project number ME021911, through the Maine Agricultural and Forest Experiment Station. J.M.H. was supported by the U.S. Department of Agriculture, National Institute of Food and Agriculture Predoctoral Fellowship 2020-67034-31743. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Author Contributions
J.M.H., L.C., D.B., J.B., T.H., and S.L.I. conceived and designed the experiments. J.M.H., L.C., D.B., J.B., and M.K. performed the experiments. J.M.H., L.C., D.B., J.B., M.K., and S.L.I. analyzed the data. J.M.H., L.C., D.B., J.B., and S.L.I. wrote the manuscript. P.L.M., G.M.M., T.Z., Y.L., and S.L.I. provided critical revisions. All authors read and approved the final manuscript.
Competing Interests
The authors declare no competing financial interests.
References
Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JC, Chan FK, Sung JJ, Kaplan GG. 2017. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390:2769–2778. https://doi.org/10.1016/S0140-6736(17)32448-0.
Kaplan GG, Ng SC. 2017. Globalization, Westernization, and the changing epidemiology of inflammatory bowel disease. Gastroenterology 152:313–321. https://doi.org/10.1053/j.gastro.2016.10.020.
Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. 2017. Ulcerative colitis. Lancet 389:1756–1770. https://doi.org/10.1016/S0140-6736(16)32126-2.
Jess T, Gamborg M, Matzen P, Munkholm P, Sørensen TI. 2005. Increased risk of intestinal cancer in Crohn’s disease and ulcerative colitis: a meta-analysis of population-based cohort studies. Gastroenterology 129:812–820. https://doi.org/10.1053/j.gastro.2005.06.023.
Lewis JD, Abreu MT. 2017. Diet as a trigger or therapy for inflammatory bowel diseases. Gastroenterology 152:398–414.e6. https://doi.org/10.1053/j.gastro.2016.10.019.
Zallot C, Quilliot D, Chevaux JB, Peyrin-Biroulet C, Guillotin D, Guéant JL, Colin C, Peyrin-Biroulet L. 2013. Dietary beliefs and behavior among inflammatory bowel disease patients. Inflamm Bowel Dis 19:66–72. https://doi.org/10.1002/ibd.23016.
Hou JK, Abraham B, El-Serag H. 2011. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 106:563–573. https://doi.org/10.1038/ajg.2011.44.
Zhang Y, Kolonel LN, Hankin JH, Nomura AM. 1994. Vegetable, fruit, and vitamin supplement intakes and colorectal cancer risk: the multiethnic cohort study. Am J Epidemiol 159:389–398. https://doi.org/10.1093/aje/kwh043.
Fahey JW, Holtzclaw WD, Wehage SL, Wade KL, Stephenson KK, Talalay P. 2002. A liquid chromatography-tandem mass spectrometry method for the simultaneous quantitation of glucosinolates and isothiocyanates in urine. Anal Biochem 305:119–124. https://doi.org/10.1006/abio.2002.5653.
Keck AS, Finley JW. 2004. Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and selenium. Integr Cancer Ther 3:5–12. https://doi.org/10.1177/1534735403261831.
Murillo G, Mehta RG. 2001. Cruciferous vegetables and cancer prevention. Nutr Cancer 41:17–28. https://doi.org/10.1080/01635581.2001.9680607.
Kushad MM, Brown AF, Kurilich AC, Juvik JA, Klein BP, Wallig MA, Jeffery EH. 1999. Variation of glucosinolates in vegetable crops of Brassica oleracea. J Agric Food Chem 47:1541–1548. https://doi.org/10.1021/jf980985s.
Zhang Y, Talalay P, Cho CG, Posner GH. 1992. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci U S A 89:2399–2403. https://doi.org/10.1073/pnas.89.6.2399.
Holst B, Williamson G. 2004. A critical review of the bioavailability of glucosinolates and related compounds. Nat Prod Rep 21:425–447. https://doi.org/10.1039/b309143b.
Conaway CC, Wang CX, Pittman B, Yang YM, Schwartz JE, Tian D, McIntee EJ, Hecht SS, Chung FL. 2002. Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit NNK-induced lung tumorigenesis in A/J mice. Carcinogenesis 23:107–114. https://doi.org/10.1093/carcin/23.7.107.
Fahey JW, Zhang Y, Talalay P. 1997. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci U S A 94:10367–10372. https://doi.org/10.1073/pnas.94.19.10367.
Myzak MC, Karplus PA, Chung FL, Dashwood RH. 2004. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 64:5767–5774. https://doi.org/10.1158/0008-5472.CAN-04-1326.
Meeran SM, Patel SN, Tollefsbol TO. 2010. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS One 5
. https://doi.org/10.1371/journal.pone.0011457.
Brooks JD, Paton VG, Vidanes G. 2001. Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol Biomarkers Prev 10:949–954.
Clarke JD, Dashwood RH, Ho E. 2008. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett 269:291–304. https://doi.org/10.1016/j.canlet.2008.04.018.
Bansal P, Bansal R, Villalobos-Martin J, Goyal S, Ghanchi S, Li R, Fan D, Abbott KR, Delk B, Wang J, Chung FL, Dashwood RH, Rajamanickam S. 2020. Sulforaphane induces a distinct epigenetic signature by modifying histone H3 lysine 9 acetylation in human colon cancer cells. Carcinogenesis 41:165–176. https://doi.org/10.1093/carcin/bgz126.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 2018. Red meat and processed meat. IARC Monogr Eval Carcinog Risks Hum 114:1–501.
Ma XK, Xing SZ, Yu W, Niu HY, Wei YQ, Liu YF, Zhao Z, Wang Y, Zheng QF, Zhao H, Xu RH. 2018. Effect of pretreatment with sulforaphane on histone acetylation in cancer cells. J Agric Food Chem 66:9697–9706. https://doi.org/10.1021/acs.jafc.8b03288.
Zhang Y. 2004. Cancer-preventive isothiocyanates: measurement of human exposure and mechanism of action. Mutat Res 555:173–190. https://doi.org/10.1016/j.mrfmmm.2004.06.021.
Charron CS, Scheerens JC, Clevidence BA, Novotny JA. 2007. Absorption and excretion of glucosinolates and isothiocyanates from horseradish root (Armoracia rusticana). J Agric Food Chem 55:1938–1942. https://doi.org/10.1021/jf062712z.
Dinkova-Kostova AT, Fahey JW, Wade KL, Jenkins SN, Wehage SL, Zhang Y, Talalay P. 2007. Induction of the phase 2 response in mouse and human skin by sulforaphane-containing broccoli sprout extracts. Cancer Epidemiol Biomarkers Prev 16:847–851. https://doi.org/10.1158/1055-9965.EPI-06-0934.
James D, Devaraj S, Bellur P, Lakkanna S, Vicini J, Boddupalli S. 2012. Novel concepts of broccoli sulforaphanes and disease: modulation of epigenetics. Nutr Rev 70:654–665. https://doi.org/10.1111/j.1753-4887.2012.00526.x.
Yang L, Palliyaguru DL, Kensler TW. 2016. Frugal chemoprevention: targeting Nrf2 with foods rich in sulforaphane. Semin Oncol 43:146–153. https://doi.org/10.1053/j.seminoncol.2015.09.001.
Finley JW, Jeffery EH. 2009. Emerging concepts in broccoli research. Am J Clin Nutr 90:1–2. https://doi.org/10.3945/ajcn.2009.27726B.
Baena S, Beltrán B. 2014. The role of sulforaphane in cancer chemoprevention and health benefits: a mini-review. J Med Food 17:688–692. https://doi.org/10.1089/jmf.2013.3091.
Clarke JD, Hsu A, Williams DE, Dashwood RH, Stevens JF, Yamamoto M, Ho E. 2011. Metabolism and tissue disposition of sulforaphane in Nrf2 knockout and wild-type mice. Pharm Res 28:3171–3179. https://doi.org/10.1007/s11095-011-0529-7.
Gasper AV, Al-Janobi A, Smith JA, Bacon JR, Fortun P, Atherton C, Taylor MA, Hawkey CJ, Barrett DA, Mithen RF. 2005. Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am J Clin Nutr 82:1283–1291. https://doi.org/10.1093/ajcn/82.6.1283.
Nkrumah-Elie YM, Rees H, Tennant KG, Ma H, Ward SJ, Tang L, Zhang Y. 2012. Development and application of a liquid chromatography-tandem mass spectrometry method for measurement of sulforaphane in human plasma. Anal Biochem 423:81–87. https://doi.org/10.1016/j.ab.2012.01.019.
Valgimigli L, Iori R. 2009. Antioxidant and pro-oxidant capacities of ITCs. Environ Mol Mutagen 50:222–237. https://doi.org/10.1002/em.20458.
Basten GP, Bao Y, Williamson G. 2002. Sulforaphane and its ITCs inhibit the invasion of human tumor cells in vitro. Cancer Lett 185:57–64. https://doi.org/10.1016/S0304-3835(02)00212-3.
Fahey JW, Haristoy X, Dolan PM, Kensler TW, Scholtus I, Stephenson KK, Talalay P, Lozniewski A. 2002. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci U S A 99:7610–7615. https://doi.org/10.1073/pnas.112203099.
Fujioka N, Yamamoto M, Kim M, Mimaki Y, Tanaka H, Taniguchi T, Yamanaka M, Ikeda T, Saito M, Nishikawa A, Sakai T. 2016. Antiproliferative effects of natural sulforaphane and its metabolite, sulforaphane-cysteine, on human breast cancer cells. Anticancer Res 36:211–218.
Xu C, Shen G, Yuan X, Kim JH, Gopalkrishnan A, Keum YS, Nair SS, Hebbar V, Kim JH, Hu R, Wang X, Kumar A, Chong S, Posner GH, Jackson R, Dashwood RH, Fahey JW, Talalay P, Kong AN. 2006. ERK and JNK signaling pathways are involved in sulforaphane-induced apoptosis of human prostate cancer cells. Cancer Res 66:5828–5835. https://doi.org/10.1158/0008-5472.CAN-05-4027.
Mahn A, Angulo Y. 2020. Factors affecting the stability of sulforaphane in broccoli. J Sci Food Agric 100:4848–4854. https://doi.org/10.1002/jsfa.10605.
Rungapamestry V, Duncan AJ, Fuller Z, Ratcliffe B. 2007. Effect of cooking brassica vegetables on the subsequent hydrolysis and metabolic fate of glucosinolates. Proc Nutr Soc 66:69–81. https://doi.org/10.1017/S0029665107005319.
Okunade O, Niranjan K, Ghawi SK, Methven L. 2018. Supplementation of bread rolls with mustard flour reduces blood glucose, cholesterol and triglyceride concentrations in normoglycemic male subjects. J Funct Foods 42:86–93. https://doi.org/10.1016/j.jff.2017.12.019.
Vermeulen M, van den Berg R, Freidig AP, van Bladeren PJ, Vaes WH. 2006. Association between consumption of cruciferous vegetables and concentrations of isothiocyanate mercapturic acids in blood and urine in humans. Cancer Epidemiol Biomarkers Prev 15:1006–1011. https://doi.org/10.1158/1055-9965.EPI-05-0842.
Hayes JD, Kelleher MO, Eggleston IM. 2008. The cancer chemopreventive actions of phytochemicals derived from glucosinolates. Eur J Nutr 47:73–88. https://doi.org/10.1007/s00394-008-2009-8.
Steinkellner H, Rabot S, Freywald C, Nobis EC, Schmid R, Chabicovsky M, Knasmüller S, Kassie F. 2001. Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens. Mutat Res 480–481:285–297. https://doi.org/10.1016/s0027-5107(01)00188-3.
Okunade O, Niranjan K, Ghawi SK, Methven L. 2018. Supplementation of bread rolls with mustard flour reduces blood glucose, cholesterol and triglyceride concentrations in normoglycemic male subjects. J Funct Foods 42:86–93. https://doi.org/10.1016/j.jff.2017.12.019.
Suparmi Suparmi, Crozier A, Zhang Q, Saleh N, Mullen W, Lean ME, Crozier A, Sharma RA. 2008. Effects of dietary hydroxycinnamates on human plasma antioxidant capacity and H(2)O(2)-induced DNA damage in human lymphocytes. Free Radic Biol Med 45:1301–1311. https://doi.org/10.1016/j.freeradbiomed.2008.07.015.
Jeffery EH, Brown AF, Kurilich AC, Keck AS, Matusheski N, Klein BP, Juvik JA. 2003. Variation in content of bioactive components in broccoli. J Food Compos Anal 16:323–330. https://doi.org/10.1016/S0889-1575(03)00045-0.
Nakamura Y, Kawakami M, Yoshihiro A, Miyoshi N, Ohigashi H, Osawa T, Uchida K. 2004. Antioxidant properties of phase II enzyme inducer sulforaphane in human monocytic cells. Cancer Res 64:516–522. https://doi.org/10.1158/0008-5472.can-03-2048.
Hayes JD, McMahon M, Chowdhry S, Dinkova-Kostova AT. 2010. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid Redox Signal 13:1713–1748. https://doi.org/10.1089/ars.2010.3221.
--
Holman, R. E., & Ishaq, S. E. (2023). Steamed Broccoli Sprouts Modulate the Gut Microbiota. mSystems, 8(2), e00123-23.